Mitochondrial and protein homeostasis pathways are transcriptionally impaired in islets during type 1 diabetes pathogenesis
Cuaycal, A. E.; Butterworth, E. A.; Stimpson, S.; Chen, J.; Lenchik, N. I.; Baratta, L. A.; Phelps, E. A.; Grieshaber, S.; Atkinson, M. A.; QIAN, W.-J.; Campbell-Thompson, M.; Gerling, I. C.; Mathews, C. E.
Show abstract
The decline in first-phase insulin response (FPIR) during the presymptomatic period of type 1 diabetes (T1D) is well established. In-situ functional studies with pancreas tissue slices showed that {beta}-cell loss of glucose-responsiveness was independent of T-cell infiltration into islets in recent-onset T1D cases. However, the mechanisms driving {beta}-cell dysfunction before the onset of T1D remain unclear. In pancreas tissue from donors across the natural history of T1D, we utilized an in-situ, whole-islet phenotypical and transcriptomic approach to unravel novel targets in the glucose-stimulus coupled secretion pathway that are similarly impaired in T-cell infiltrated and non-infiltrated islets. Specifically, we observed that islets from autoantibody positive (single(s) or multiple(m) AAb+) donors exhibited activation of post-transcriptional gene regulation along with reduced protein translation, processing in the endoplasmic reticulum (ER), and ER stress. Disrupted mitochondrial metabolism and bioenergetics were prominent in islets from multiple AAb+ and T1D donors with disease durations [≤]7 years. In addition, T1D islets presented reduced mitochondrial protein import, quality control, and dynamics, together with downregulated genes in insulin secretory pathways. During infiltration, these pathways remain dysregulated while immune/inflammatory transcripts were increased. These studies identified novel mechanisms of {beta}-cell dysregulation before symptomatic onset and independent of T-cell infiltration in T1D pathogenesis.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Natural protection from type 1 diabetes in Non Obese Diabetic (NOD) mice is characterised by a unique pancreatic islet phenotype 94%
- Gut-derived GLP-1 released by rare sugar D-allulose cooperates with insulin to activate left-sided vagal afferents and enhance insulin sensitivity 94%
- β-cell SENP1 facilitates responsiveness to incretins and limits oral glucose intolerance in high fat fed mice 93%
Similar papers in this journal
Similar papers in this journal
- Spatial transcriptomics from pancreas and local draining lymph node tissue reveals a lymphotoxin-β signature in human type 1 diabetes 97%
- Single-cell analysis of the human pancreas in type 2 diabetes using multi-spectral imaging mass cytometry 95%
- Pericyte dysfunction and impaired vasomotion are hallmarks of islets during the pathogenesis of type 1 diabetes 95%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.